12.02.2021

|

Speaking Engagements

Over the past couple years, sales of non-CBD cannabinoids, such as Delta-8 THC, have skyrocketed, partially due to claims that these substances are legal under the 2018 Farm Act. But are these chemically modified cannabinoids “hemp-derived?” This panel will explore the legal status of synthetic cannabinoids in the context of FDA’s regulatory posture toward other synthetic ingredients in food and dietary supplements. Speakers will also discuss how to address safety concerns related to these substances.

Click here for more information.